Citations

Institution: Mayo Clinic Clear

Showing 10 of 108162 citations.

Volumetric analysis of tumor control following subtotal and near‐total resection of vestibular schwannoma
Jacob, Jeffrey T. , Carlson, Matthew L. , Driscoll, Colin L. W., Link, Michael J. , Driscoll, Colin L.

The Laryngoscope | November 24, 2015 | Volume: 126 | Issue: 8 | Pages: 1877-1882

10.1002/lary.25779 | PMID 27426941 Get It

Objectives/HypothesisThe primary goals of microsurgery for vestibular schwannoma (VS) include preservation of neural function and complete tumor removal. In a subset of patients, adherent tumor remnant may be intentionally left behind in order to minimize risk of new neurologic deficits. It is not well established if residual tumor volume predicts likelihood of tumor remnant growth.MethodsPatients with sporadic VS who underwent near‐total (NTR) or subtotal (STR) VS resection between 2000 and 2014 were reviewed. Postoperative tumor remnants were volumetrically contoured using T1‐weighted gadolinium‐enhanced magnetic resonance imaging obtained within 3 months of surgery.ResultsA total of 103 patients met study criteria, and the median duration of radiographic follow‐up was 41 months (mean 56.1 months, range 12–150 months). Fifty patients underwent NTR and 53 received STR. Overall 14 (13.6%) tumors recurred at a median of 41.0 months. Patients who underwent STR were over 13 times more likely to recur compared with those treated with NTR (hazard ratio 13.31; 95% confidence interval 1.71–103.91; P = 0.014). The median time to recurrence following NTR was 124 months compared to 32 months after STR (P < 0.001).ConclusionsLong‐term follow‐up in patients undergoing incomplete resection is essential. Near‐total resection has a significantly lower rate of recurrence compared to STR. Maximal surgical resection should be the goal in VS microsurgery. The decision to pursue less than complete resection should be based on intraoperative impression, when it is felt that continued dissection of adherent disease would compromise neurologic outcome.Level of Evidence4. Laryngoscope, 126:1877–1882, 2016
Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled Disease
Geyer, Holly L. , Scherber, Robyn M. , Dueck, Amylou C. , Kiladjian, Jean‐Jacques , Xiao, Zhijian , Slot, Stefanie , Zweegman, Sonja , Sackmann, Federico, Fuentes, Ana Kerguelen, Hernández‐Maraver, Dolores , Döhner, Konstanze , Harrison, Claire , Radia, Deepti , Muxí, Pablo , Besses, Carlos , Cervantes, Francisco , Johansson, Peter , Andréasson, Björn , Rambaldi, Alessandro , Barbui, Tiziano , Bonatz, Karin, Reiter, Andreas , Boyer, Françoise, Étienne, Gabriel , Ianotto, Jean‐Christophe , Ranta, Dana, Roy, Lydia , Cahn, Jean‐Yves, Ferrari, Maria Luisa, Birgegård, Gunnar , Xu, Junqing , Zhang, Peihong , Boekhorst, Peter A.W. te , Commandeur, Suzan, Schouten, Harry C. , Pahl, Heike L. , Grießhammer, Martin , Stegelmann, Frank , Lehmann, Thomas , Senyak, Zhenya, Passamonti, Francesco , Samuelsson, Jan , Geyer, Holly, Scherber, Robyn, Hernández-Maraver, Dolores, Johansson, Peter L, Maldonado, Norman, Barosi, Giovanni , Ferrari, Maria L, Xu, Zefeng, Sun, Xiujuan, te Boekhorst, Peter A W, Schouten, Harry, Griesshammer, Martin, Dueck, A. C. , Kosiorek, Heidi , Zweegman, Sonja , Cahn, Jean‐Yves , Maldonado, Norman D. , Gale, Robert Peter , Xu, Zefeng , Zhang, Yue , Sun, Xiujuan , Vannucchi, Alessandro M. , Mesa, Ruben A. , Kiladjian, Jean-Jacques , Rambaldi, Alessandro , Ianotto, Jean-Christophe , Passamonti, Francesco

Journal of Clinical Oncology | November 24, 2015 | Volume: 34 | Issue: 2 | Pages: 151-159

10.1200/jco.2015.62.9337 | PMID 26598745 Get It

Purpose Polycythemia vera (PV) is a myeloproliferative neoplasm (MPN) associated with disabling symptoms and a heightened risk of life-threatening complications. Recent studies have demonstrated the effectiveness of JAK inhibitor therapy in patients with PV patients who have a history of prior hydroxyurea (HU) use (including resistance or intolerance), phlebotomy requirements, and palpable splenomegaly. We aimed to determine how these features contribute alone and in aggregate to the PV symptom burden. Patients and Methods Through prospective evaluation of 1,334 patients with PV who had characterized symptom burden, we assessed patient demographics, laboratory data, and the presence of splenomegaly by disease feature (ie, known HU use, known phlebotomy requirements, splenomegaly). Results The presence of each feature in itself is associated with a moderately high symptom burden (MPN symptom assessment form [SAF] total symptom score [TSS] range, 27.7 to 29.2) that persists independent of PV risk category. In addition, symptoms incrementally increase in severity with the addition of other features. Patients with PV who had all three features (PV-HUPS) faced the highest total score (MPN-SAF TSS, 32.5) but had similar individual symptom scores to patients with known HU use (PV-HU), known phlebotomy (PV-P), and splenomegaly (PV-S). Conclusion The results of this study suggest that patients with PV who have any one of the features in question (known HU use, known phlebotomy, or splenomegaly) have significant PV-associated symptoms. Furthermore, it demonstrates that many PV symptoms remain severe independent of the number of features present.
An Examination of Electronic Cigarette Content on Social Media: Analysis of E-Cigarette Flavor Content on Reddit
Wang, Lei , Leischow, Scott J. , Okamoto, Janet , Zhan, Yongcheng , Li, Qiudan , Zeng, Daniel Dajun

International Journal of Environmental Research and Public Health | November 24, 2015 | Volume: 12 | Issue: 11 | Pages: 14916-14935

10.3390/ijerph121114916 | PMID 26610541 Get It

In recent years, the emerging electronic cigarette (e-cigarette) marketplace has shown great development prospects all over the world. Reddit, one of the most popular forums in the world, has a very large user group and thus great influence. This study aims to gain a systematic understanding of e-cigarette flavors based on data collected from Reddit. Flavor popularity, mixing, characteristics, trends, and brands are analyzed. Fruit flavors were mentioned the most (n = 15,720) among all the posts and were among the most popular flavors (n = 2902) used in mixed blends. Strawberry and vanilla flavors were the most popular for e-juice mixing. The number of posts discussing e-cigarette flavors has increased sharply since 2014. Mt. Baker Vapor and Hangen were the most popular brands discussed among users. Information posted on Reddit about e-cigarette flavors reflected consumers’ interest in a variety of flavors. Our findings suggest that Reddit could be used for data mining and analysis of e-cigarette-related content. Understanding how e-cigarette consumers’ view and utilize flavors within their vaping experience and how producers and marketers use social media to promote flavors and sell products could provide valuable information for regulatory decision-makers.
Crowdsourcing Assessment of Surgeon Dissection of Renal Artery and Vein During Robotic Partial Nephrectomy: A Novel Approach for Quantitative Assessment of Surgical Performance
Powers, Mary K., Boonjindasup, Aaron, Pinsky, Michael R. , Dorsey, Philip, Maddox, Michael, Su, Li-Ming, Gettman, Matthew T., Sundaram, Chandru P. , Castle, Erik P., Lee, Jason Y. , Gettman, Matthew, Lee, Benjamin R.

Journal of Endourology | November 24, 2015 | Volume: 30 | Issue: 4 | Pages: 447-452

10.1089/end.2015.0665 | PMID 26597352 Get It

Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial
Piccart, Martine , Holmes, Eileen , Baselga, José , Azambuja, Evandro de , Dueck, Amylou C. , Viale, Giuseppe , Zujewski, Jo Anne , Goldhirsch, Aron, Armour, Alison, McCullough, Ann E. , Dolci, Stella, McFadden, Eleanor, Holmes, Andrew , Tonghua, Liu, Eidtmann, Holger, Dinh, Phuong , Cosimo, Serena Di , Tjulandin, Sergei , Im, Young‐Hyuck , Huang, Chiun‐Sheng , Wolff, Antonio C. , Jackisch, Christian , Láng, István, Boyle, Frances , Gómez, Henry , Gelber, Richard D. , Perez, Edith A. , Piccart-Gebhart, Martine, de Azambuja, Evandro, Pritchard, Kathleen I. , Holmes, Andrew P, Di Cosimo, Serena, Harbeck, Nadia , Dièras, Véronique , Hillman, David W. , Untch, Michael , Smith, Ian , Xu, Binghe , Suter, Thomas, Dueck, A. C. , Zujewski, Jo Anne , Tonghua, Liu, Xu, Binghe , Suter, Thomas , Wolff, Antonio C , de Azambuja, Evandro , Huang, Chiun-Sheng

Journal of Clinical Oncology | November 23, 2015 | Volume: 34 | Issue: 10 | Pages: 1034-1042

10.1200/jco.2015.62.1797 | PMID 26598744 Get It

Background Lapatinib (L) plus trastuzumab (T) improves outcomes for metastatic human epidermal growth factor 2–positive breast cancer and increases the pathologic complete response in the neoadjuvant setting, but their role as adjuvant therapy remains uncertain. Methods In the Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization trial, patients with centrally confirmed human epidermal growth factor 2–positive early breast cancer were randomly assigned to 1 year of adjuvant therapy with T, L, their sequence (T→L), or their combination (L+T). The primary end point was disease-free survival (DFS), with 850 events required for 80% power to detect a hazard ratio (HR) of 0.8 for L+T versus T. Results Between June 2007 and July 2011, 8,381 patients were enrolled. In 2011, due to futility to demonstrate noninferiority of L versus T, the L arm was closed, and patients free of disease were offered adjuvant T. A protocol modification required P ≤ .025 for the two remaining pairwise comparisons. At a protocol-specified analysis with a median follow-up of 4.5 years, a 16% reduction in the DFS hazard rate was observed with L+T compared with T (555 DFS events; HR, 0.84; 97.5% CI, 0.70 to 1.02; P = .048), and a 4% reduction was observed with T→L compared with T (HR, 0.96; 97.5% CI, 0.80 to 1.15; P = .61). L-treated patients experienced more diarrhea, cutaneous rash, and hepatic toxicity compared with T-treated patients. The incidence of cardiac toxicity was low in all treatment arms. Conclusion Adjuvant treatment that includes L did not significantly improve DFS compared with T alone and added toxicity. One year of adjuvant T remains standard of care.
Exome Variant Mining in Familial Parkinson Disease
Toft, Mathias , Ross, Owen A. , Ross, Owen A , Toft, Mathias

JAMA Neurology | November 23, 2015 | Volume: 73 | Issue: 1 | Pages: 21

10.1001/jamaneurol.2015.3536 | PMID 26595415 Get It

Association of Elevated Amyloid Levels With Cognition and Biomarkers in Cognitively Normal People From the Community
Petersen, Ronald C. , Wiste, Heather J. , Weigand, Stephen D. , Rocca, Walter A. , Roberts, Rosebud O., Lowe, Val J. , Geda, Yonas E. , Jack, Clifford R. , Mielke, Michelle M. , Knopman, David S. , Pankratz, V. Shane , Machulda, Mary M. , Jack, Clifford R , Geda, Yonas E

JAMA Neurology | November 23, 2015 | Volume: 73 | Issue: 1 | Pages: 85

10.1001/jamaneurol.2015.3098 | PMID 26595683 Get It

Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis
Singh, Siddharth , Stroud, Andrea , Holubar, Stefan D. , Sandborn, William J. , Pardi, Darrell S. , Holubar, Stefan D

Cochrane Database of Systematic Reviews | November 23, 2015 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1002/14651858.cd001176.pub3 | PMID 26593456 Get It

In reference to “national cohort study of opioid analgesic dose and risk of future hospitalization”
Sundaragiri, Pranathi R., Vallabhajosyula, Saraschandra , Shah, Neel , Shah, Neel B, Vallabhajosyula, Saraschandra

Journal of Hospital Medicine | November 23, 2015 | Volume: 11 | Issue: 2 | Pages: 155-156

10.1002/jhm.2514 | PMID 26595452 Get It

Identification of HDAC6‐Selective Inhibitors of Low Cancer Cell Cytotoxicity
Gaisina, Irina N. , TUECKMANTEL, W., Ugolkov, Andrey , Shen, Sida , Hoffen, Jessica, Dubrovskyi, Oleksii, Mazar, Andrew P. , Schoon, Renee A., Billadeau, Daniel D. , Kozikowski, Alan P.

ChemMedChem | November 23, 2015 | Volume: 11 | Issue: 1 | Pages: 81-92

10.1002/cmdc.201500456 | PMID 26592932 Get It

AbstractThe histone deacetylases (HDACs) occur in 11 different isoforms, and these enzymes regulate the activity of a large number of proteins involved in cancer initiation and progression. The discovery of isoform‐selective HDAC inhibitors (HDACIs) is desirable, as it is likely that such compounds would avoid some of the undesirable side effects found with the first‐generation inhibitors. A series of HDACIs previously reported by us were found to display some selectivity for HDAC6 and to induce cell‐cycle arrest and apoptosis in pancreatic cancer cells. In the present work, we show that structural modification of these isoxazole‐based inhibitors leads to high potency and selectivity for HDAC6 over HDAC1–3 and HDAC10, while unexpectedly abolishing their ability to block cell growth. Three inhibitors with lower HDAC6 selectivity inhibit the growth of cell lines BxPC3 and L3.6pl, and they only induce apoptosis in L3.6pl cells. We conclude that HDAC6 inhibition alone is insufficient for disruption of cell growth, and that some degree of class 1 HDAC inhibition is required. Moreover, the highly selective HDAC6Is reported herein that are weakly cytotoxic may find use in cancer immune system reactivation.